COMMUNIQUÉS West-GlobeNewswire

-
Paratek Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018
23/07/2018 -
RedHill Biopharma Announces Uplisting to Nasdaq Global Market
23/07/2018 -
Midatech Pharma US announces Co-Promotion Agreement with Bausch Health Companies Inc. for the Exclusive Right to Promote NeutraSal® to the Oncology Market in United States
23/07/2018 -
Helius Medical Technologies, Inc. Announces Results of Matters Submitted for Vote at 2018 Annual Shareholder Meeting
23/07/2018 -
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone
23/07/2018 -
Arcturus Therapeutics Achieves Program Milestones and Refines Agreement with Cystic Fibrosis Foundation Therapeutics
23/07/2018 -
Epizyme Appoints Dr. Shefali Agarwal as Chief Medical Officer
23/07/2018 -
Agios to Webcast Conference Call of Second Quarter 2018 Financial Results on August 2, 2018
23/07/2018 -
Intra-Cellular Therapies Announces Publication Highlighting ITI-214 Mechanism of Action and Describing Positive Results in Preclinical Models of Heart Failure
23/07/2018 -
Auxly Announces Issuance of Sales Licence for Kolab Project and Provides Update on Saskatchewan Retail Strategy
23/07/2018 -
Reata Announces Positive Phase 2 Data for Bardoxolone Methyl in CKD Caused by Alport Syndrome and Autosomal Dominant Polycystic Kidney Disease
23/07/2018 -
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
23/07/2018 -
HEXO Reaches Major Milestone in Ongoing Expansion Plans
23/07/2018 -
HEXO franchit une étape importante dans ses plans d'expansion en cours
23/07/2018 -
Sernova Completes Oversubscribed Private Placement of $2,754,000
23/07/2018 -
PotNetwork Holding's Diamond CBD Scores Over $300,000 in Sales at the 38th Las Vegas CHAMPS Show
23/07/2018 -
Transactions under Novozymes’ stock buyback program
23/07/2018 -
Novo Nordisk A/S: Share repurchase programme
23/07/2018 -
Immunicum AB (publ) Announces Protocol Approval by the FDA Enabling the Initiation of Expanded Multi-indication Phase Ib/II Combination Trial
23/07/2018
Pages